Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Talis Biomedical Corporation’s current trading price is -54.18% away from its 52-week high, while its distance from the 52-week low is 30.62%. The stock’s price range during this period has varied between $0.42 and $1.20. The company, active in the Healthcare sector, saw a trading volume of around 1.07 million for the day, considerably higher average daily volume of 86970.0 observed over the last three months.
Currently, the stock price of Talis Biomedical Corporation (TLIS) is $0.55. In the most recent trading session, the stock underwent a significant upswing, peaking at $0.478 after opening at $0.4685. The stock touched a low of $0.4602 before closing at $0.47.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Talis Biomedical Corporation had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $1.20 on 08/24/22, while the lowest price during the same period was $0.42 on 12/30/22.
How Financial Performance Impacts Market Capitalization
Talis Biomedical Corporation (TLIS) has experienced a quarterly decline of -4.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.35M and boasts a workforce of 242 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5358, with a change in price of +0.0890. Similarly, Talis Biomedical Corporation recorded 106,550 in trading volume during the last 100 days, posting a change of +19.35%.
How TLIS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TLIS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
TLIS Stock Stochastic Average
As of today, the raw stochastic average of Talis Biomedical Corporation over the last 50 days is at 69.64%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 79.05%. Further, the company’s Stochastic %K and %D values for the last 20 days were 45.46% and 31.39%, respectively.
TLIS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 23.38%. However, over the past six months, we’ve seen a weaker performance of 15.14%. The price of TLIS fallen by 10.24% over the last 30 days. And in the last five days, it has surged by 20.99%.